{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:04:15Z","timestamp":1780495455009,"version":"3.54.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Skin biopsies are essential to establish a diagnosis in many skin diseases. Utilization has been increasing rapidly and represents a significant health care cost. There are no benchmarks or baselines to guide the practice of skin biopsies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To create a reference data set of biopsy behavior among dermatologists.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Five hundred eighty-eight dermatologists belonging to the American Dermatological Association (ADA) were surveyed. Two hundred eighty-seven responded with 128 of those providing biopsy data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>The mean percentage of biopsies that were malignant was 44.5%. This varied by subspecialty with a mean of 41.7%, 57.4%, and 4.1% of biopsies performed by general dermatologists, Mohs micrographic surgeons, and pediatric dermatologists, respectively. By category or diagnosis, the biopsies were 22.7% basal cell carcinoma, 12.0% SCC, 10.2% benign neoplasms, 10.0% nevi, 8.0% actinic keratosis, 7.6% seborrheic keratosis, 7.5% inflammatory disorders, 6.1% SCC in situ, 5.3% dysplastic nevus, 5.1% benign skin, 1.5% melanoma in situ, 1.4% melanoma, 0.9% lentigines, 0.8% other malignancies, 0.6% infectious, 0.2% not otherwise specified, and 0.1% atypical lesions. There was a statistically significant difference in biopsy results between different dermatological subspecialties.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>These results should help elucidate dermatologic practice patterns and thus create opportunities to improve dermatologic care and reduce health care costs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000001188","type":"journal-article","created":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T18:11:42Z","timestamp":1495908702000},"page":"1348-1357","source":"Crossref","is-referenced-by-count":13,"title":["Use of Skin Biopsies Among Dermatologists"],"prefix":"10.1097","volume":"43","author":[{"given":"David A.","family":"Weinstein","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida;"},{"name":"TriHealth Good Samaritan Hospital, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasank","family":"Konda","sequence":"additional","affiliation":[{"name":"University of Chicago Pritzker School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett M.","family":"Coldiron","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio; and"},{"name":"The Skin Cancer Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the us population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamadermatol.2014.1773","article-title":"Scope of physician procedures independently billed by mid-level providers in the office setting","volume":"150","author":"Coldiron","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamadermatol.2015.0173","article-title":"Biopsy use in skin cancer diagnosis: comparing dermatology physicians and advanced practice professionals","volume":"151","author":"Nault","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09546634.2010.512951","article-title":"How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis","volume":"23","author":"Wilson","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"R7-20230814","first-page":"1208","article-title":"Documenting dermatology practice: ratio of cutaneous tumors biopsied that are malignant","volume":"30","author":"Green","year":"2004","journal-title":"Dermatol Surg"},{"key":"R8-20230814","first-page":"1158","article-title":"Diagnosis of nonmelanoma skin cancer\/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies","volume":"33","author":"Mogensen","year":"2007","journal-title":"Dermatol Surg"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(02)00679-4","article-title":"Diagnostic accuracy of dermoscopy","volume":"3","author":"Kittler","year":"2002","journal-title":"Lancet Oncol"},{"key":"R10-20230814","first-page":"527","article-title":"Economic costs avoided by diagnosing melanoma six months earlier justify >100 benign biopsies","volume":"15","author":"Aires","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2011.07.019","article-title":"Accuracy in melanoma detection: a 10-year multicenter survey","volume":"67","author":"Argenziano","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/bjd.13121","article-title":"Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety","volume":"171","author":"Malvehy","year":"2014","journal-title":"Br J Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/DSS.0000000000000253","article-title":"Importance of physical appearance in patients with skin cancer","volume":"41","author":"Sobanko","year":"2015","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201711000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:11:55Z","timestamp":1692040315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201711000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001188","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}